Lisata Therapeutics, Inc.LSTANASDAQ
Loading
Year-over-year free cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | 2.78% |
| Q3 2025 | 16.11% |
| Q2 2025 | 26.63% |
| Q1 2025 | -19.92% |
| Q4 2024 | -79.83% |
| Q3 2024 | 52.34% |
| Q2 2024 | 24.82% |
| Q1 2024 | -72.70% |
| Q4 2023 | -13.56% |
| Q3 2023 | 14.36% |
| Q2 2023 | 48.95% |
| Q1 2023 | -26.21% |
| Q4 2022 | -61.46% |
| Q3 2022 | 24.07% |
| Q2 2022 | 6.11% |
| Q1 2022 | -20.97% |
| Q4 2021 | 7.44% |
| Q3 2021 | -7.51% |
| Q2 2021 | 41.23% |
| Q1 2021 | -43.10% |
| Q4 2020 | -58.41% |
| Q3 2020 | -178.33% |
| Q2 2020 | 205.84% |
| Q1 2020 | -0.55% |
| Q4 2019 | 5.32% |
| Q3 2019 | 5.55% |
| Q2 2019 | 13.98% |
| Q1 2019 | -80.31% |
| Q4 2018 | 37.69% |
| Q3 2018 | 17.07% |
| Q2 2018 | 6.65% |
| Q1 2018 | -58.21% |
| Q4 2017 | -195.18% |
| Q3 2017 | 75.06% |
| Q2 2017 | 47.22% |
| Q1 2017 | -162.45% |
| Q4 2016 | 38.24% |
| Q3 2016 | 12.17% |
| Q2 2016 | 20.58% |
| Q1 2016 | 2.85% |